Alcon Inc. logo

Alcon Inc. (A2LC34)

Market Closed
10 Feb, 19:55
B3 B3
R$
41. 28
+0.07
+0.17%
R$
- Market Cap
- P/E Ratio
1.06% Div Yield
4 Volume
- Eps
R$ 41.21
Previous Close
Day Range
41.28 41.28
Year Range
39.2 55.6
Want to track A2LC34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

A2LC34 closed Tuesday higher at R$41.28, an increase of 0.17% from Monday's close, completing a monthly increase of 0.17% or R$0.07. Over the past 12 months, A2LC34 stock lost -6.1%.
A2LC34 is not paying dividends to its shareholders.
The last earnings report, released on Yesterday at 12:00 AM, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on B3 (BRL).

A2LC34 Chart

Alcon Inc. (A2LC34) FAQ

What is the stock price today?

The current price is R$41.28.

On which exchange is it traded?

Alcon Inc. is listed on B3.

What is its stock symbol?

The ticker symbol is A2LC34.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.06%.

What is its market cap?

As of today, no market cap data is available.

Has Alcon Inc. ever had a stock split?

No, there has never been a stock split.

Alcon Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
David J. Endicott CEO
B3 Exchange
- ISIN
CH Country
25,599 Employees
13 May 2025 Last Dividend
- Last Split
- IPO Date

Overview

Alcon Inc. is a global leader in eye care, specializing in the research, development, manufacturing, distribution, and sales of a wide range of eye care products. Catering to both eye care professionals and patients, Alcon's mission is to enhance vision and improve people's lives through innovative products and solutions. The company's portfolio spans across surgical procedures and vision care, addressing a broad spectrum of eye health needs. Originally founded in 1945 as Alcon Universal S.A., the company underwent a name change to Alcon Inc. in December 2001 and has since established its headquarters in Geneva, Switzerland, marking its presence as a key player in the eye care industry on a global scale.

Products and Services

Alcon Inc.'s offerings are divided into two main segments: Surgical and Vision Care, each catering to distinct aspects of eye health and surgery.

  • Surgical Segment:
  • Within the surgical field, Alcon provides a comprehensive array of products including equipment, instrumentation, diagnostics, intraocular lenses (IOLs), and other implantables, along with various consumables. These specialized products support a wide range of procedures from cataract surgery to vitreoretinal operations. Notable products within this segment include the Centurion Vision System, LenSx Laser System for cataract treatment, Constellation Vision Systems for vitreoretinal surgeries, and the WaveLight Lasers for LASIK treatments. Additionally, Alcon offers innovative solutions like the NGENUITY 3D Visualization System and the ORA system for enhanced surgical precision and outcomes. Custom surgical packs and a variety of manual surgical instruments further complement Alcon’s surgical offerings.

  • Vision Care Segment:
  • Alcon’s Vision Care segment focuses on enhancing daily eye health and visual comfort through a wide range of products. This includes daily disposable, reusable, and color-enhancing contact lenses designed to meet diverse needs and preferences. Beyond corrective lenses, Alcon provides solutions for common eye concerns such as dry eye, ocular allergies, and glaucoma, as well as products for contact lens care. The segment is also home to ocular vitamins and redness relievers, aimed at maintaining overall eye health and comfort.

Contact Information

Address: Chemin de Blandonnet 8
Phone: 41 58 911 20 00